Polypharmacy in Osteoporosis Treatment

被引：12

作者：

McConnell, Megan ^{[1
]}

Shieh, Albert ^{[2
,3
]}

机构：

[1] UCLA Div Endocrinol Diabet & Hypertens, 10833 Le Conte Ave,CHS 57-145, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, Dept Med, 10833 Le Conte Ave,CHS 57-145, Los Angeles, CA 90095 USA

[3] 10945 Le Cone Ave,Peter B Ueberroth Bldg,Suite 233, Los Angeles, CA 90095 USA

来源：

CLINICS IN GERIATRIC MEDICINE | 2022年 / 38卷 / 04期

关键词：

Polypharmacy; Osteoporosis; Fractures; Bisphosphonates; Denosumab; Teriparatide; Abaloparatide; Romosozumab; LOW BONE-DENSITY; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; ZOLEDRONIC ACID; HIP FRACTURE; DOUBLE-BLIND; OLDER WOMEN; RISK; PREVENTION; TERIPARATIDE;

D O I：

10.1016/j.cger.2022.05.011

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

页码：715 / 726

页数：12

共 47 条

[1] Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis [J].

Barrionuevo, Patricia ;

Kapoor, Ekta ;

Asi, Noor ;

Alahdab, Fares ;

Mohammed, Khaled ;

Benkhadra, Khalid ;

Almasri, Jehad ;

Farah, Wigdan ;

Sarigianni, Maria ;

Muthusamy, Kalpana ;

Al Nofal, Alaa ;

Haydour, Qusay ;

Wang, Zhen ;

Murad, Mohammad Hassan .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05) :1623-1630

[2] Loss of treatment benefit due to low compliance with bisphosphonate therapy [J].

Beest, F. J. A. Penning-van ;

Erkens, J. A. ;

Olson, M. ;

Herings, R. M. C. .

OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) :511-517

[3] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard ;

Reid, Ian R. ;

Boonen, Steven ;

Cauley, Jane A. ;

Cosman, Felicia ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Mautalen, Carlos ;

Mesenbrink, Peter ;

Hu, Huilin ;

Caminis, John ;

Tong, Karen ;

Rosario-Jansen, Theresa ;

Krasnow, Joel ;

Hue, Trisha F. ;

Sellmeyer, Deborah ;

Eriksen, Erik Fink ;

Cummings, Steven R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822

[4] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[5] 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension [J].

Bone, Henry G. ;

Wagman, Rachel B. ;

Brandi, Maria L. ;

Brown, Jacques P. ;

Chapurlat, Roland ;

Cummings, Steven R. ;

Czerwinski, Edward ;

Fahrleitner-Pammer, Astrid ;

Kendler, David L. ;

Lippuner, Kurt ;

Reginster, Jean-Yves ;

Roux, Christian ;

Malouf, Jorge ;

Bradley, Michelle N. ;

Daizadeh, Nadia S. ;

Wang, Andrea ;

Dakin, Paula ;

Pannacciulli, Nicola ;

Dempster, David W. ;

Papapoulos, Socrates .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07) :513-523

[6] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE EXECUTIVE SUMMARY [J].

Camacho, Pauline M. ;

Petak, Steven M. ;

Binkley, Neil ;

Diab, Dima L. ;

Eldeiry, Leslie S. ;

Farooki, Azeez ;

Harris, Steven T. ;

Hurley, Daniel L. ;

Kelly, Jennifer ;

Lewiecki, E. Michael ;

Pessah-Pollack, Rachel ;

McClung, Michael ;

Wimalawansa, Sunil J. ;

Watts, Nelson B. .

ENDOCRINE PRACTICE, 2020, 26 (05) :564-570

[7] Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].

Chesnut, CH ;

Skag, A ;

Christiansen, C ;

Recker, R ;

Stakkestad, JA ;

Hoiseth, A ;

Felsenberg, D ;

Huss, H ;

Gilbride, J ;

Schimmer, RC ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249

[8] Osteoporosis [J].

Compston, Juliet E. ;

McClung, Michael R. ;

Leslie, William D. .

LANCET, 2019, 393 (10169) :364-376

[9] Romosozumab Treatment in Postmenopausal Women with Osteoporosis [J].

Cosman, F. ;

Crittenden, D. B. ;

Adachi, J. D. ;

Binkley, N. ;

Czerwinski, E. ;

Ferrari, S. ;

Hofbauer, L. C. ;

Lau, E. ;

Lewiecki, E. M. ;

Miyauchi, A. ;

Zerbini, C. A. F. ;

Milmont, C. E. ;

Chen, L. ;

Maddox, J. ;

Meisner, P. D. ;

Libanati, C. ;

Grauer, A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (16) :1532-1543

[10] Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab [J].

Cummings, S. R. ;

McCulloch, C. .

OSTEOPOROSIS INTERNATIONAL, 2020, 31 (06) :1019-1021

← 1 2 3 4 5 →